Signant Health Adds Agentic AI for Clinical Supply Forecasting

Signant Health, a provider of eClinical solutions for clinical research, has introduced Forecasting & Planning Assist, an AI-powered capability designed to help clinical supply professionals improve forecasting and planning for global clinical trials. Forecasting & Planning Assist™ puts the full analytical power of the technology at the fingertips of clinical supply experts, enabling them to query data, execute configuration tasks, and monitor supply and enrollment risks across their portfolio in seconds through plain-language prompts, with complete oversight and control throughout.

The new feature, built into the company's clinical supply platform, uses agentic AI to analyze study data, generate supply forecasts, and recommend planning strategies for investigational products. The tool is designed to help clinical supply teams evaluate multiple planning scenarios, anticipate changes in patient enrollment and optimize inventory levels across trial sites while allowing users to review and validate AI-generated recommendations before implementation.

Forecasting & Planning Assist™ builds on Signant's clinical supply Forecasting & Planning solution, which has a proven track record of helping clinical trial sponsors reduce costs, cut medication waste, and decrease emergency shipments across complex global portfolios, accelerating how teams work within that platform and amplifying the value it already delivers.

The capability is intended to reduce the manual effort associated with forecasting and supply planning while improving operational efficiency and helping ensure investigational products are available where and when they are needed during clinical studies.

Posted by MedCloudInsider Editors on 08/03/2026